Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 63% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 0 citations in OpenAlex.
Iqra NazishReta Lila Weston Institute of Neurological Studies and Department of Movement neuroscience, UCL Queen Square Institute of Neurology, London WC1N 1PJ, UK.ORCID 0009-0008-9113-0922
Adamantios MamaisCenter for Translational Research in Neurodegenerative Disease, Department of Neurology, University of Florida, Gainesville, FL 32610, USA.
Anna MallachDepartment of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London WC1N 1PJ, UK.
Conceicao BettencourtDepartment of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.ORCID 0000-0001-9090-7690
Alice KaganovichCell Biology and Gene Expression Section, National Institute on Aging, Bethesda, MD 20892, USA.
Thomas WarnerReta Lila Weston Institute of Neurological Studies and Department of Movement neuroscience, UCL Queen Square Institute of Neurology, London WC1N 1PJ, UK.
John HardyDepartment of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
Patrick A LewisDepartment of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.ORCID 0000-0003-4537-0489
Jennifer PocockDepartment of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London WC1N 1PJ, UK.ORCID 0000-0001-5812-9331
Mark R CooksonCell Biology and Gene Expression Section, National Institute on Aging, Bethesda, MD 20892, USA.
Rina BandopadhyayReta Lila Weston Institute of Neurological Studies and Department of Movement neuroscience, UCL Queen Square Institute of Neurology, London WC1N 1PJ, UK.ORCID 0000-0003-3502-8815
National Hospital for Neurology and Neurosurgery · GBInstitute on Aging · USUniversity of Florida · USUniversity of London · GB
Funding
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASER01NS110188 · NINDS · UNIVERSITY OF FLORIDA · PI LAVOIE, MATTHEW J · 2018 to 2022
$2.3M
Dysregulation of iron homeostasis by mutant LRRK2 in human neuronsR21AG077269 · NIA · UNIVERSITY OF FLORIDA · PI MAMAIS, ADAMANTIOS · 2023 to 2024
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2. · full record | OpenQuestion